Caxton Associates (New York)’s Codexis CDXS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-29,121
Closed -$81.5K 426
2023
Q2
$81.5K Hold
29,121
0.01% 460
2023
Q1
$121K Hold
29,121
0.02% 455
2022
Q4
$136K Buy
+29,121
New +$160K 0.01% 407

Other funds holding CDXS

Caxton Associates (New York)'s CDXS Position: Q3 2023 in Review

Caxton Associates (New York) sold out of Codexis (CDXS) in Q3 2023, closing a stake of 29,121 shares — an estimated $81.5K sold.

Caxton Associates (New York) first reported a position in CDXS in Q4 2022 and held it in 3 quarters. The position peaked at $136K in Q4 2022. 122 funds tracked by Wall St. Rank hold CDXS as of Q3 2023.

  • Caxton Associates (New York) reported no remaining Codexis position as of Q3 2023 after selling out during the quarter.
  • Caxton Associates (New York) sold 29,121 Codexis shares in Q3 2023, an estimated $81.5K.
  • Caxton Associates (New York) first reported a position in Codexis in Q4 2022 and held it in 3 quarters.
  • Caxton Associates (New York)'s Codexis position peaked at $136K in Q4 2022.
  • 122 funds tracked by Wall St. Rank held Codexis as of Q3 2023.

Based on Caxton Associates (New York)'s 13F filing for Q3 2023, filed 14 Nov 2023.